Clinical Trials Browser

Phase 2 × Overall Survival × Atorvastatin × Clear all

NCT03275376 2021-03-16

Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma

Phase 2 Terminated

Overall Survival